nach oben

Reactions Weekly

Erschienen in:

01.05.2022 | Case report

Azathioprine

Hepatotoxicity, gastric intolerance and blood disorder: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Patients age and sex obtained via personal communication with the author.

Casajus A, et al. Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers. Advances in Therapy 39: 1743-1753, No. 4, Apr 2022. Available from: URL: http://doi.org/10.1007/s12325-022-02067-8

Titel: Azathioprine
Hepatotoxicity, gastric intolerance and blood disorder: 3 case reports
Publikationsdatum: 01.05.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-15824-6

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Nivolumab

Empagliflozin

Tacrolimus

Insulin-glargine

Ipilimumab/nivolumab

Eltrombopag